AOS vs CORT · P/E 19, rev $1.00B vs P/E 199, rev $421.1M
Smith AO Corporation (AOS) versus Corcept Therapeutics Incorporated (CORT) — a side-by-side from cached financials, not a winner call.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Latest reported AOS revenue for 2026-06-30 was $1.00B. Net income was $124.9M. Revenue was up 6.2% from 2026-03-31 to 2026-06-30. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Latest reported CORT revenue for 2026-06-30 was $421.1M. Net income was $11.2M. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
AOS currently screens at market cap $9.73B and trailing P/E 19.1. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Not investment advice. Open the AOS and CORT stock pages for the full models.
Not investment advice.